pharmaceuticals, namely highly branched polymers conjugated with drugs, genetic material, and/or target directors and/or kits thereof, for use in treating genetic disorders, cancer, diseases which respond to genetic manipulation, and other diseases in humans or animals responding to the conjugated drugs

custom manufacturing of chemicals, for use by others, in the manufacturing of high purity reagents, pharmaceutical intermediates, adhesives, binders, coalescing agents and molecular calibrating agents